Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
LIVE NEWCASTLE DISEASE VIRUS (VG/GA) COMPONENT LIVE INFECTIOUS BRONCHITIS VIRUS (H120) COMPONENT
Merial Animal Health Limited
QI01AD
Frozen suspension for nebuliser suspension
Immunological - Live Vaccine
Fowl - Chicken
2007-11-02
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10857/071/001 Case No: 7001184 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: MERIAL ANIMAL HEALTH LIMITED SANDRINGHAM HOUSE, SANDRINGHAM AVENUE, HARLOW BUSINESS PARK, HARLOW, ESSEX CM19 5TG, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: HATCHPAK AVINEW IB H120 The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation,unless revoked, shall continue in force from 03/04/2009 until 01/11/2012. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 04/04/2009_ _CRN 7001184_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT HATCHPAK AVINEW IB H120 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Frozen suspension for nebuliser suspension. Yellow. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES One day old chickens 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In one day-old chickens: - active immunisation against Newcastle disease in order to reduce mortality and clinical signs linked to Newcastle disease Прочитайте повний документ